rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    SANA
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Wedbush cuts Sana Biotechnology stock price target on model changes
      Nov 9Investing.comSANA
      Sana: Q3 Earnings Snapshot
      Nov 5Yahoo FinanceSANA
      Top Biotech Stock: Guggenheim Names Surrozen as Best Pick

      Investing.com -- Guggenheim Securities has identified Surrozen, Inc. as its top pick in the biotechnology sector, assigning a Buy rating with a price target of $42.00. The firm hosted management from Surrozen to discuss recent developments in retinal vascular disease treatments and the company’s clinical pipeline.

      Oct 15Yahoo FinanceSANA
      Sana Biotechnology: A Shot At Diabetes
      Oct 13Seeking AlphaSANA
      H.C. Wainwright Remains a Buy on Sana Biotechnology (SANA)

      Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailSANA
      Sana Biotechnology at Morgan Stanley conference: diabetes push leads
      Sep 14Investing.comSANAMS
      Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push
      Sep 10Investing.comSANA
      Sana Biotechnology at wells fargo healthcare conference: two programs near clinic
      Sep 8Investing.comSANAWFC
      Did Sana Biotechnology, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
      Sep 7MorningstarSANA
      Sana Biotechnology to Present at September 2026 Investor Conferences

      SEATTLE, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September. The presentations will feature a business overview and update. Sana will present at the 2026 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Tuesday, September 8, 2026.Sana will present at Citi’s 2026 Biopharma Back-to-School Conf

      Sep 1Yahoo FinanceSANA
      Biotech Breakout: What's in focus after Moderna's cancer win? (MRNA:NASDAQ)
      Aug 24Seeking AlphaMRNASANA

      This is the newest page. Registered accounts read further back.